VESSELIA KAFOZOFF: Open Payments
NPI 1538357132 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $82 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $58 |
| Incyte Corporation | 3 | $54 |
| Galderma Laboratories, L.P. | 1 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Organon LLC | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| Biofrontera Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
Products named: SKYRIZI, OPZELURA, NEMLUVIO, Sotyktu, SPEVIGO, HADLIMA, Leqselvi, VTAMA.
Industry payments across NJ — which companies pay providers there.
